Pulmatrix Inc (PULM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

99 HAYDEN AVENUE LEXINGTON, MA 02421

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSEā„¢ technology. The Company's proprietary product pipeline includes treatments for serious lung diseases such as allergic bronchopulmonary aspergillosis ('ABPA') and lung cancer, as well as neurologic disorders such as acute migraine. Pulmatrix's product candidates are based on iSPERSEā„¢, its proprietary engineered dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes.

Data as of 2021-07-19 09:16:30 -0400
Market Cap46.968 Million Shares Outstanding56.249 Million Avg 30-day Volume414.57 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.26 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.74235 52-week High/Low3.04 / 0.82 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -14.2683
Data provided by IEX Cloud
View SEC Filings from PULM instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 26 26 0.0% 10 (0.59%) 10 (0.58%) 0.0%
13F shares: 7.036 Million 8.145 Million -13.62% 2.992 Million 5.662 Million -47.15%
% Ownership 12.5081 23.6723 -47.16% 5.32 16.4564 -67.67%
New Positions: 5 4 25.0% 2 1 100.0%
Increased Positions 10 7 42.86% 3 3 0.0%
Closed Positions 4 3 33.33% 2 1 100.0%
Reduced Positions 5 8 -37.5% 3 3 0.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PULM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PULM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HIGGINS MICHAEL J

  • Director
0 2021-01-28 1

IWICKI MARK T

  • Director
0 2021-01-28 1

RAAD TEOFILO DAVID CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-01-28 1

MUNSHI AMIT

  • Director
0 2021-01-28 1

SIEGERT MICHELLE VICE PRESIDENT, FINANCE

  • Officer
0 2021-01-28 1

BATYCKY RICHARD P.

  • Director
0 2021-01-28 1

CABELL CHRISTOPHER

  • Director
0 2021-01-28 1

BAZEMORE TODD

  • Director
0 2021-01-28 3

GILLIS STEVEN

  • Director
No longer subject to file 2020-08-28 1

MCGUIRE TERRANCE

  • Director
0 2019-05-16 0

DUKE WILLIAM E. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-05-16 0

SHERMAN MATTHEW L

  • Director
0 2019-05-16 0

CLARKE ROBERT W. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2018-06-05 0

HAVA DAVID L. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-06-05 0

ROACH JAMES M. CHIEF MEDICAL OFFICER

  • Officer
0 2018-06-05 0

MCGUIRE TERRANCE

FLINT JONATHAN A

POLARIS VENTURE MANAGEMENT CO IV LLC

POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LP

POLARIS VENTURE PARTNERS IV LP

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

  • Director
  • 10% Owner
5,180,235 2018-04-03 0

GILLIS STEVEN

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
3,436,456 2018-04-03 0

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-04-03 0

GRAVES KURT

  • Director
0 2016-02-03 0

ROCKLAGE SCOTT M

  • Director
0 2016-02-03 0

OCULUS INNOVATIVE SCIENCES, INC.

  • 10% Owner
0 2015-06-16 0

MAKI DAVID

  • Director
436,388 2015-06-15 0

CONLEY RICHARD K

  • Director
0 2015-04-30 0

FRENCH GREGORY M

  • Director
0 2015-04-30 0

AKAO AKIHISA

  • Director
0 2015-04-30 0

HARISH SAMEER CHIEF FINANCIAL OFFICER

  • Officer
74,600 2014-05-11 0

ALIMI HOJABR CEO AND CHIEF SCIENCE OFFICER

  • Officer
  • Director
125,000 2014-05-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HIGGINS MICHAEL J - Director

2016-02-25 12:54:48 -0500 2026-02-03 A 8,800 a 8,800 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PULMATRIX INC PULM 2021-07-23 22:15:03 UTC -9.6032 9.6832 150000
PULMATRIX INC PULM 2021-07-23 21:45:03 UTC -9.6032 9.6832 150000
PULMATRIX INC PULM 2021-07-23 21:15:03 UTC -9.6032 9.6832 150000
PULMATRIX INC PULM 2021-07-23 20:45:03 UTC -9.4108 9.4908 150000
PULMATRIX INC PULM 2021-07-23 20:15:05 UTC -9.4108 9.4908 150000
PULMATRIX INC PULM 2021-07-23 19:45:03 UTC -9.4108 9.4908 200000
PULMATRIX INC PULM 2021-07-23 19:15:03 UTC -9.4108 9.4908 200000
PULMATRIX INC PULM 2021-07-23 18:45:03 UTC -9.478 9.558 200000
PULMATRIX INC PULM 2021-07-23 18:15:03 UTC -9.478 9.558 200000
PULMATRIX INC PULM 2021-07-23 17:45:03 UTC -9.478 9.558 200000
PULMATRIX INC PULM 2021-07-23 17:15:02 UTC -9.478 9.558 200000
PULMATRIX INC PULM 2021-07-23 16:45:02 UTC -9.7467 9.8267 200000
PULMATRIX INC PULM 2021-07-23 16:15:03 UTC -9.7467 9.8267 200000
PULMATRIX INC PULM 2021-07-23 15:45:02 UTC -9.7467 9.8267 200000
PULMATRIX INC PULM 2021-07-23 15:15:03 UTC -9.7467 9.8267 200000
PULMATRIX INC PULM 2021-07-23 14:45:03 UTC -9.4007 9.4807 200000
PULMATRIX INC PULM 2021-07-23 14:15:03 UTC -9.4007 9.4807 200000
PULMATRIX INC PULM 2021-07-23 13:45:03 UTC -9.4007 9.4807 200000
PULMATRIX INC PULM 2021-07-23 13:15:03 UTC -9.4007 9.4807 150000
PULMATRIX INC PULM 2021-07-23 12:45:03 UTC -9.4007 9.4807 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund PULM -1500.0 shares, $-1995.0 2021-03-31 N-PORT

Elevate your investments